LENZ Therapeutics, Inc. (LENZ)
NASDAQ · Healthcare
LENZ Therapeutics, Inc. Operating Income 2024–2025
LENZ Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2024 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- LENZ Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was -44.1 M, a 160.68% increase year-over-year.
- LENZ Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was -96.8 M.
- LENZ Therapeutics, Inc. annual operating income for 2025 was -91.1 M, a 55.50% increase from 2024.
- LENZ Therapeutics, Inc. annual operating income for 2024 was -58.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
LENZ Therapeutics, Inc. Operating Income — FAQ
LENZ Therapeutics, Inc. (LENZ) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is LENZ Therapeutics, Inc.'s operating income?
LENZ Therapeutics, Inc. (LENZ) reported operating income of -$91M for fiscal 2025.
Where can I see LENZ's operating income history?
The chart and table above show LENZ Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.